rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Douglas Blayney

Director

Company insider

Files Form 4 as: Director, Artelo Biosciences.

In numbers

Trades disclosed
23
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
29 Aug 2019
Last trade
17 Jul 2026
Last filed
21 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ARTL Artelo BiosciencesDirector · Biotechnology · last 17 Jul 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
17 Jul 2026filed 21 Jul 2026ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—136 at $0.00filing
17 Jul 2026filed 21 Jul 2026ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—136 at $0.00filing
30 Jan 2026filed 2 Feb 2026ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—292 at $0.00filing
30 Jan 2026filed 2 Feb 2026ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—292 at $0.00filing
20 Dec 2024filed 23 Dec 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—1,750 at $0.00filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,200filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—9,300filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,083filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—1,200filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—9,300filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—1,083filing
4 Aug 2023filed 8 Aug 2023ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—1,083 at $0.00filing
30 Jun 2023filed 3 Jul 2023ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—667 at $0.00filing
24 Jun 2022filed 27 Jun 2022ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Robert Martin EmanueleDirector · Director at Artelo Biosciences, filing Form 4 there in the last year
Connie MatsuiDirector · Director at Artelo Biosciences, filing Form 4 there in the last year
Tamara A. FavoritoDirector · Director at Artelo Biosciences, filing Form 4 there in the last year
Steven KellyDirector · Director at Artelo Biosciences, filing Form 4 there in the last year
Gregory ReyesDirector · Director at Artelo Biosciences, filing Form 4 there in the last year